J. B. Chemicals & Pharmaceuticals 관리
관리 기준 확인 2/4
J. B. Chemicals & Pharmaceuticals CEO는 Nikhil Chopra, Dec2020 에 임명되었습니다 의 임기는 3.92 년입니다. 총 연간 보상은 ₹ 71.34M, 49.2% 로 구성됩니다. 49.2% 급여 및 50.8% 보너스(회사 주식 및 옵션 포함). 는 ₹ 69.90M 가치에 해당하는 회사 주식의 0.026% 직접 소유합니다. 69.90M. 경영진과 이사회의 평균 재임 기간은 각각 1.8 년과 4.1 년입니다.
주요 정보
Nikhil Chopra
최고 경영자
₹71.3m
총 보상
| CEO 급여 비율 | 49.2% |
| CEO 임기 | 3.9yrs |
| CEO 소유권 | 0.03% |
| 경영진 평균 재임 기간 | 1.8yrs |
| 이사회 평균 재임 기간 | 4.1yrs |
최근 관리 업데이트
Recent updates
We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 27
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Nov 09J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) Business Is Yet to Catch Up With Its Share Price
Sep 24Most Shareholders Will Probably Agree With J. B. Chemicals & Pharmaceuticals Limited's (NSE:JBCHEPHARM) CEO Compensation
Aug 15J. B. Chemicals & Pharmaceuticals Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Aug 11These 4 Measures Indicate That J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Using Debt Reasonably Well
Jun 28J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | ₹6b |
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹71m | ₹35m | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹65m | ₹37m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹59m | ₹18m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹32m | ₹7m | ₹4b |
보상 대 시장: Nikhil 의 총 보상 ($USD 846.14K )은 Indian 시장( $USD 610.84K ).
보상과 수익: Nikhil 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Nikhil Chopra (51 yo)
3.9yrs
테뉴어
₹71,338,000
보상
Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.9yrs | ₹71.34m | 0.026% ₹ 69.9m | |
| Assistant Vice President – Human Resource | no data | ₹10.48m | 0.0025% ₹ 6.7m | |
| Chief Financial Officer | less than a year | ₹12.74m | 데이터 없음 | |
| President of Operations | no data | ₹28.44m | 데이터 없음 | |
| Vice President of Finance & Accounts | no data | ₹9.48m | 데이터 없음 | |
| Vice President of Information & Technology | 9.8yrs | ₹10.70m | 데이터 없음 | |
| Vice President of HR & Administration | 8.2yrs | ₹13.80m | 0.00084% ₹ 2.3m | |
| Vice President of Legal | 1.8yrs | ₹11.49m | 데이터 없음 | |
| President of Global Business | no data | ₹42.09m | 0.012% ₹ 31.5m | |
| Executive Vice President of Operations of Daman | 1.3yrs | ₹17.24m | 0.0048% ₹ 13.1m | |
| Executive Vice President of Supply Chain Operations | no data | ₹19.54m | 0.0084% ₹ 22.7m | |
| Executive Vice President | less than a year | ₹18.12m | 0.0032% ₹ 8.7m |
1.8yrs
평균 재임 기간
51yo
평균 연령
경험이 풍부한 관리: JBCHEPHARM 의 관리팀은 경험 (평균 재직 기간 1.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Whole-Time Director | 4.1yrs | ₹71.34m | 0.026% ₹ 69.9m | |
| Chairman of Biotech Laboratories (Pty ) Ltd | no data | 데이터 없음 | 데이터 없음 | |
| Non-Executive Independent Chairman | less than a year | 데이터 없음 | 데이터 없음 | |
| Non-Executive & Independent Director | 4.3yrs | ₹7.50m | 데이터 없음 | |
| Non-Executive Director | 4.3yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive & Non-Independent Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Non-Executive Director | 3.8yrs | 데이터 없음 | 데이터 없음 | |
| Non-Executive & Independent Director | 4.3yrs | ₹7.50m | 데이터 없음 |
4.1yrs
평균 재임 기간
64.5yo
평균 연령
경험이 풍부한 이사회: JBCHEPHARM 의 이사회는 경험(평균 재직 기간 4.1 년)으로 간주됩니다.